The increasingly popular class of therapies known as GLP-1 receptor agonists are impacting metabolic control , but the route of administration is becoming a key factor . Previously, these effective medications were offered solely in capsule form. However, innovative transdermal systems are now being introduced, prompting many individuals to questio